Archives: Speakers

Agata Wiesiołek is a graduate of the Intercollegiate Faculty of Biotechnology of the University of Gdańsk, Poland.

She has been working in the area of clinical trials and with AstraZeneca since 2006. Agata’s current role is Senior Director, Study Management Late-Phase Development in Respiratory & Immunology area, supporting AstraZeneca clinical operations worldwide. Agata’s  global experience includes strict project management in clinical trials & leading non-drug project initiatives leading to improvements and optimization ways of working in various Therapeutical Areas for different stages of trials.

Agata has been involved in managing and leading clinical research projects for more than 15 years and she also took a part of shaping and transforming AstraZeneca’s global Clinical Trials Site in Warsaw.

Estrella began her ‘scientific odyssey’ at the University of Navarra, Spain, where she gained a PhD in Genetic Toxicology.  Following this, Estrella held at post-doctoral position at ICI (now Astra Zeneca) in Macclesfield, UK. At ICI Estrella’s focus was on novel anti-tumor drugs in the pre-clinical phase. Subsequently Estrella returned to Spain where she joined Almirall as a Clinical Research Scientist. Since then, Estrella has amassed a 29 year career with the company- taking on roles of increasing demand and responsibility, including Head of Allergy Therapeutic Area and Head of Clinical Development Operations- to the role she holds today.

Estrella leads her group and is responsible for clinical trials worldwide. Since Almirall do not have affiliates fully involved in clinical development, the company externalizes all clinical trials, with a strategic focus on keeping only core competencies- particularly for pivotal studies- in-house. In this capacity Estrella has worked with dozens of CROs and service providers managing Phase I to Phase IV clinical trials of all sizes, from small single centre studies to global programs involving hundreds of sites and thousands of patients. Her responsibility is covering the selecting, negotiation, contracting, managing and final evaluation of the CROs responsible for the worldwide clinical development, in order to deliver on the agreed timelines, quality and cost.

She has been responsible for ensuring Clinical Development for Aclidinium bromide in COPD was performed worldwide from the operational point of view on time, budget and quality, among other development from Almirall.

Now fully focus on Dermatology development, managing trials worldwide mainly in Psoriasis, Acné, Atopic Dermatitis, Actinic Keratosis, among other indications.

Currently Europe Market Manager for Plant Protein at Roquette, Sandrine is working mainly for the markets of meat and dairy alternatives.
Graduated a post graduate diploma in Food Science and Nutrition, she had several experiences in the Food market (petfood, baby food, specialized nutrition) in R&D position, and starts to work in Ingredients industry in 2008. She has taken several functions : application, technical support, innovation. Sandrine has a strong experience in project management and technical support to Commercial teams.

Fred van Jaarsveld is managing director of Zitron Nederland since 2009.
Fred van Jaarsveld is a graduate of HAN, the Netherlands in automotive engineering.
Fred van Jaarsveld has almost 30 years experience working in the field of engineering, installation and maintenance of tunnel ventilation systems and tunnel fans in a leading role.